ClinicalTrialsFinder

Progressive Astrocytoma, IDH-Mutant, Grade 4 Clinical Trials in Rochester, Minnesota

1 recruitingRochester, Minnesota

Showing 1–1 of 1 trials

Recruiting
Phase 2

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Glioblastoma, IDH-wildtypeRecurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype+6 more
Mayo Clinic36 enrolled1 locationNCT07301268